{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:05Z","timestamp":1787071085631,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Development and validation of a simple and convenient computational program in MATLAB environment for estimating the tumor control probability (TCP) and the normal tissue complication probability (NTCP), as a decision support system for routine plan evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We developed an in-house software using MATLAB 2016b (Mathworks) for estimating TCP and NTCP named as RBMODELV1. The program contains Niemierko free equivalent uniform dose (EUD) program code provided in authors research article. For rest of radiobiological (RB) models in the software separate coding is performed. The program accepts cumulative dose\u2013volume histogram file in (.txt) format containing two columns dose and volume. A set of two RB parameters were prepared, default and user-dependent in excel sheet named as RBDATA. We cross-validated results of RBMODELV1 software with BioSuite software for Poisson's TCP model and Lyman-Kutcher-Burman (LKB) model. A set of total 20 patient's data of head and neck site took under study and respective TCP and NTCP calculated by all the RB models and compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>This is the first study in which we tried to establish correlation between the mean doses (EUD) received by parallel structure (parotid gland and oral cavity) and predicted percentage of NTCP values. It is found that mean dose in the range of 35\u201340 Gy for parotid gland can result in more than 50% NTCP predicted by all four RB models. Similarly oral cavity receiving mean dose in the range of 53\u201358 Gy can results in more than 35% NTCP predicted by all the four models. There is &lt;3% variation observed between TCP calculated by BioSuite and RBMODELV1 software and &lt;4% variation observed between predicted NTCP for parotid gland and oral cavity OAR from LKB model by both the software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We created simple software RBMODELV1 which can be used as a research tool as well as decision support system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_330_20","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:37:21Z","timestamp":1668645441000},"page":"1697-1705","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of an indigenous, radiobiological model-based tumor control probability and normal tissue complication probability estimation software for routine plan evaluation in clinics"],"prefix":"10.4103","volume":"18","author":[{"given":"Ganeshkumar","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinav","family":"Bharati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritusha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Mourya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-39-20241021","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0971-6203.89971","article-title":"Dose volume histogram analysis and comparison of different radiobiological models using in-house developed software","volume":"36","author":"Oinam","year":"2011","journal-title":"Med Phys"},{"key":"R2-39-20241021","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3390\/cancers3022421","article-title":"Comparison of dose response models for predicting normal tissue complications from cancer radiotherapy: Application in rat spinal cord","volume":"3","author":"Adamus-G\u00f3rka","year":"2011","journal-title":"Cancers (Basel"},{"key":"R3-39-20241021","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejmp.2015.10.091","article-title":"RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation","volume":"32","author":"Chang","year":"2016","journal-title":"Phys Med"},{"key":"R4-39-20241021","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0360-3016(02)03986-X","article-title":"Comparing different NTCP models that predict the incidence of radiation pneumonitis","volume":"55","author":"Seppenwoolde","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-39-20241021","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1118\/1.3685447","article-title":"The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM","volume":"39","author":"Allen Li","year":"2012","journal-title":"Med Phys"},{"key":"R6-39-20241021","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1118\/1.1568978","article-title":"CERR: A computational environment for radiotherapy research","volume":"30","author":"Deasy","year":"2003","journal-title":"Med Phys"},{"key":"R7-39-20241021","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09553000902748567","article-title":"A free software for the evaluation and comparison of dose response models in clinical radiotherapy (DORES)","volume":"85","author":"Tsougos","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"R8-39-20241021","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1088\/0031-9155\/51\/22\/001","article-title":"Dose response explorer: An integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships","volume":"51","author":"El Naqa","year":"2006","journal-title":"Phys Med Biol"},{"key":"R9-39-20241021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1120\/jacmp.v5i1.1970","article-title":"A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets","volume":"5","author":"Warkentin","year":"2004","journal-title":"J Appl Clin Med Phys"},{"key":"R10-39-20241021","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1259\/bjr\/20476567","article-title":"Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite","volume":"85","author":"Uzan","year":"2012","journal-title":"Br J Radiol"},{"key":"R11-39-20241021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmp.2007.07.001","article-title":"A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy","volume":"23","author":"Gay","year":"2007","journal-title":"Phys Med"},{"key":"R12-39-20241021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: A concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"R13-39-20241021","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0360-3016(91)90173-2","article-title":"Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations","volume":"21","author":"Kutcher","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-39-20241021","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2017.09.041","article-title":"Systematic review of normal tissue complication models relevant to standard fractionation radiation therapy of the head and neck region published after the QUANTEC reports","volume":"100","author":"Brodin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-39-20241021","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0360-3016(94)00475-Z","article-title":"Radiation dose-response of human tumors","volume":"32","author":"Okunieff","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-39-20241021","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: A review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"R17-39-20241021","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1088\/0031-9155\/53\/3\/014","article-title":"Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data","volume":"53","author":"Semenenko","year":"2008","journal-title":"Phys Med Biol"},{"key":"R18-39-20241021","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/1471-2407-12-567","article-title":"Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments","volume":"12","author":"Lee","year":"2012","journal-title":"BMC Cancer"},{"key":"R19-39-20241021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1088\/0031-9155\/53\/1\/002","article-title":"A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD)","volume":"53","author":"Luxton","year":"2008","journal-title":"Phys Med Biol"},{"key":"R20-39-20241021","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-39-20241021","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1088\/0031-9155\/55\/8\/001","article-title":"Mechanistic simulation of normal-tissue damage in radiotherapy\u2013implications for dose-volume analyses","volume":"55","author":"Rutkowska","year":"2010","journal-title":"Phys Med Biol"},{"key":"R22-39-20241021","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1088\/0031-9155\/57\/11\/R75","article-title":"Monte Carlo role in radiobiological modelling of radiotherapy outcomes","volume":"57","author":"El Naqa","year":"2012","journal-title":"Phys Med Biol"},{"key":"R23-39-20241021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"R24-39-20241021","first-page":"381","article-title":"Towards a model-based patient selection strategy for proton therapy: External validation of photon-derived Normal tissue complication probability models in a head and neck proton therapy cohort","volume":"121","author":"Blanchard","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-39-20241021","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/09553002.2018.1486516","article-title":"Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: The usefulness of EUD as an indicator to rank modern photon vs. proton treatment plans","volume":"94","author":"Chaikh","year":"2018","journal-title":"Int J Radiat Biol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_330_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:14Z","timestamp":1787067674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_330_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_330_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}